Human clinical trials could begin as early as next year
A team of researchers at the University of Georgia’s Regenerative Bioscience Center and ArunA Biomedical, a UGA startup company, have developed a new treatment for stroke that reduces brain damage and accelerates the brain’s natural healing tendencies in animal models. They published their findings in the journal Translational Stroke Research.
The research team led by UGA professor Steven Stice and Nasrul Hoda of Augusta University created a treatment called AB126 using extracellular vesicles (EV), fluid-filled structures known as exosomes, which are generated from human neural stem cells.
Fully able to cloak itself within the bloodstream, this type of regenerative EV therapy appears to be the most promising in overcoming the limitations of many cell therapies—with the ability for exosomes to carry and deliver multiple doses—as well as the ability to store and administer treatment. Small in size, the tiny tubular shape of an exosome allows EV therapy to cross barriers that cells cannot.
“This is truly exciting evidence, because exosomes provide a stealth-like characteristic, invisible even to the body’s own defenses,” said Stice, Georgia Research Alliance Eminent Scholar and D.W. Brooks Distinguished Professor in the College of Agricultural and Environmental Sciences. “When packaged with therapeutics, these treatments can actually change cell progression and improve functional recovery.”
Following the administration of AB126, the researchers used MRI scans to measure brain atrophy rates in preclinical, age-matched stroke models, which showed an approximately 35 percent decrease in the size of injury and 50 percent reduction in brain tissue loss—something not observed acutely in previous studies of exosome treatment for stroke.
Outside of rodents, the results were replicated by Franklin West, associate professor of animal and dairy science, and fellow RBC members using a porcine model of stroke—the only one of its kind in the U.S.
Based on these pre-clinical results, ArunA Biomedical plans to begin human studies in 2019, said Stice, who is also chief scientific officer of ArunA Biomedical.
“Until now, we had very little evidence specific to neural exosome treatment and the ability to improve motor function,” said Stice. “Just days after stroke, we saw better mobility, improved balance and measurable behavioral benefits in treated animal models.”
Named as part of the ‘stroke belt’ region, Georgia continues to exceed the national average in stroke deaths, which is the third leading cause of death in the U.S., with more than 140,000 Americans dying each year, according to the Centers for Disease Control and Prevention.
ArunA recently unveiled advances to the company’s proprietary neural cell platform for the production of exosome manufacturing. Today, ArunA’s manufacturing process positions the company to produce AB126 exosomes at a scale to meet early clinical demand. The company has plans to expand this initiative beyond stroke for preclinical studies in epilepsy, traumatic brain and spinal cord injuries later this year.
The Latest on: Stroke treatment
- UTHealth research highlights findings on thrombectomy, post-stroke anxiety, and caregiver burden on February 19, 2019 at 4:34 am
The UTHealth unit is the only mobile stroke unit in the world that meets emergency medical services at a halfway point. Recent data shows the system is increasing patient volumes by 50 percent without ... […]
- Cerebrovascular Diseases Treatment Market 2019 – Industry Analysis, Size, Share, Strategies and Forecast To 2023 on February 19, 2019 at 2:03 am
There are various hospitals and practitioners who are adopting hormone replacement therapy which can further cause the major stroke, and the unhealthy eating habits are leading to high cholesterol lev... […]
- 4 Things Women Need to Know About Stroke on February 18, 2019 at 6:45 am
F.A.S.T. is not just an acronym; it’s also an important action: Act F.A.S.T. when a stroke happens because treatments need to happen right away. Call 911 if you think you are or someone near ... […]
- Newfoundland and Labrador stroke treatment rates lag behind rest of Canada on February 18, 2019 at 2:55 am
Developing the proper protocol and acting FAST can help stroke sufferers survive. Dr. Gregory Browne, a vascular specialist and surgeon, is part of the team with Quality of Care NL/Choosing Wisely NL ... […]
- 14 minutes that saved a life: How paramedics' quick thinking during stroke made all the difference on February 17, 2019 at 3:00 am
Neurological wisdom says "time is brain" when it comes to a stroke. The longer a person experiencing a stroke is unable to receive treatment, the worse the results for the brain and body typically wil... […]
- Stroke Disorder and Treatment Market 2019 Key Country Analysis: AstraZeneca, Pfizer, Bayer Pharma AG, Daiichi Sankyo, Novartis AG and other on February 15, 2019 at 10:03 am
The Global Stroke Disorder And Treatment Market is presumed to demonstrate a healthy CAGR during the forecast period (2016-2022) owing to the rising high blood pressure patients, asserts Market Resear... […]
- Vaccination, antiviral treatment fails to affect stroke risk from herpes zoster on February 15, 2019 at 4:59 am
Contracting herpes zoster increased risk for acute ischemic stroke, and among patients with herpes zoster, vaccination or antiviral treatment did not modify the risk, according to data presented at th... […]
- Pioneering stroke treatment is saving Stoke-on-Trent's main hospital £2.4 MILLION! on February 14, 2019 at 9:00 pm
Hundreds of stroke patients have received pioneering treatment to remove dangerous blood clots from their brain - with some able to walk out of hospital the very next day. And the procedure at the Roy... […]
- Quick treatment crucial to stroke patients on February 9, 2019 at 10:15 pm
Each and every day, medical professionals provide life-saving treatments for patients. Stroke patients, in particular, are very critical when it comes to time for treatment. When a patient ... […]
- Heart-brain connection: Community Healthcare symposium shows link between stroke, cardiac health; showcases advancements in prevention, treatment on February 8, 2019 at 5:00 am
“Stroke is the fifth-leading cause of death in the U.S. and the leading cause of disability,” says Dr. Andrea DeLeo, interventional neurologist and medical director of the Stroke Center at St. Catheri... […]
via Google News and Bing News